Miljöpåverkan
Lakosamid
Miljörisk:
Användning av lakosamid har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning:
Lakosamid är potentiellt persistent.
Bioackumulering:
Lakosamid har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula:
PEC (µg/l) = (A*109*(100-R))/(365*P*V*D*100) = 1.5*10-6*A*(100-R)
PEC = 0.02 µg/l
Where:
A = 163.32 kg (total sold amount API in Sweden year 2020, data from IQVIA)
R = 0 % removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation)
P = number of inhabitants in Sweden = 10*106
V (l/day) = volume of wastewater per capita and day = 200 (Ref I)
D = factor of dilution of waste water by surface water flow = 10 (Ref I)
Predicted No Effect Concentration (PNEC)
Ecotoxicological studies
Algae (Scenedesmus subspicatus):
Acute toxcity
EC50 72 h (growth inhibition) > 100 000 µg/l
EC50 72 h (biomass) > 100 000 µg/l
(Protocol: OECD 201)
(Ref II)
Chronic toxicity
NOEC > 100 000 µg/l
(Protocol: OECD 201)
(Ref II)
Crustacean (Daphnia magna):
NOEC 21 days (reduction in reproduction) > 32 000 µg/l
(Protocol: OECD 211)
(Ref II)
Fish (Danio rerio):
NOEC 35 days (lethality) ≥ 10 000 µg/l
(Protocol: OECD 210)
(Ref II)
Other ecotoxicity data:
PNEC = 1 000 µg/l
(The PNEC (μg/l) = 10 000/10 using results from the most sensitive chronic toxicity endpoint and an assessment factor of 10 ("reduced to 10 for three long-term results from at least three species representing three trophic levels" [Ref I, Table R.10-4]). The most sensitive species was the fish, Danio rerio for which the NOEC used was 10 000 μg/l.)
Environmental risk classification (PEC/PNEC ratio)
PEC/PNEC= 0.02 /1 000= 0.00002, i.e. PEC/PNEC ≤ 0.1 which justifies the phrase “Use of lacosamide has been considered to result in insignificant environmental risk”
Degradation
Biotic degradation
Ready degradability: Lacosamide showed 3-4 % degradation in 28 days (protocol: OECD 301) (Ref II)
Lacosamide did not pass the ready degradation test and since there is no information available on grade of mineralisation the phrase: ”lacosamide is potentially persistent.” should be used.
Bioaccumulation
Partitioning coefficient
Log Pow = 0.25 at pH 7 (Protocol: OECD 107) (Ref II)
Justification for chosen bioaccumulation phrase:
Since log Pow < 4 at pH 7, the substance has low potential for bioaccumulation.
Excretion (Metabolism)
Lacosamide is to 95 % excreted in urine to 40 % as unchanged drug, 30 % as inactive metabolite and 20 % as uncharacterized metabolite. The inactive metabolite has no pharmacological activity. (Ref II)
References
-
ECHA, European Chemicals Agency. Guidance on information requirements and chemical safety assessment, version 3.0 Feb 2016.
-
Vimpat environmental assessment, FDA application number: NDA 22-253 and 22-254. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022253s000_022254s000_EA.pdf